$2.40
-0.13[-5.14%]
At close: May 10
$2.40
0[0.00%]
After Hours: 6:04PM EDT
Taysha Gene Therapies
(NASDAQ:TSHA)Taysha Gene Therapies Stock (NASDAQ:TSHA), Quotes and News Summary
Taysha Gene Therapies Stock (NASDAQ: TSHA) stock price, news, charts, stock research, profile.
| Open | $2.540 |
| Close | $2.340 |
| Volume / Avg. | 1.408M / 2.839M |
| Day Range | 2.300 - 2.570 |
| 52 Wk Range | 0.500 - 3.890 |
| Market Cap | $448.844M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 45 |
| Short Interest | 11.7% |
| Days to Cover | 7.61 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Taysha Gene Therapies (TSHA) stock?
You can purchase shares of Taysha Gene Therapies (NASDAQ: TSHA) through any online brokerage.
Who are Taysha Gene Therapies's (TSHA) competitors?
Other companies in Taysha Gene Therapies’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
What is the target price for Taysha Gene Therapies (TSHA) stock?
The latest price target for Taysha Gene Therapies (NASDAQ: TSHA) was reported by Needham on Thursday, May 2, 2024. The analyst firm set a price target for 7.00 expecting TSHA to rise to within 12 months (a possible 191.67% upside). 28 analyst firms have reported ratings in the last year.
Current Stock Price for Taysha Gene Therapies (TSHA)?
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.4 last updated May 10, 2024 at 6:04 PM EDT.
Does Taysha Gene Therapies (TSHA) pay a dividend?
There are no upcoming dividends for Taysha Gene Therapies.
When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?
Taysha Gene Therapies’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Taysha Gene Therapies (TSHA) going to split?
There is no upcoming split for Taysha Gene Therapies.
What sector and industry does Taysha Gene Therapies (TSHA) operate in?
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.